285 related articles for article (PubMed ID: 18470911)
1. Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1.
Hedley BD; Welch DR; Allan AL; Al-Katib W; Dales DW; Postenka CO; Casey G; Macdonald IC; Chambers AF
Int J Cancer; 2008 Aug; 123(3):526-34. PubMed ID: 18470911
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation.
Samant RS; Clark DW; Fillmore RA; Cicek M; Metge BJ; Chandramouli KH; Chambers AF; Casey G; Welch DR; Shevde LA
Mol Cancer; 2007 Jan; 6():6. PubMed ID: 17227585
[TBL] [Abstract][Full Text] [Related]
3. Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1.
Metge BJ; Liu S; Riker AI; Fodstad O; Samant RS; Shevde LA
Oncology; 2010; 78(1):75-86. PubMed ID: 20215788
[TBL] [Abstract][Full Text] [Related]
4. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1.
Zhang S; Lin QD; DI W
Int J Gynecol Cancer; 2006; 16(2):522-31. PubMed ID: 16681721
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of osteopontin expression by RNA interference affects cell proliferation and chemotherapy sensitivity of breast cancer MDA-MB-231 cells.
Yang L; Wei L; Zhao W; Wang X; Zheng G; Zheng M; Song X; Zuo W
Mol Med Rep; 2012 Feb; 5(2):373-6. PubMed ID: 22143930
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer metastasis suppressor 1 regulates hepatocellular carcinoma cell apoptosis via suppressing osteopontin expression.
Wu Y; Jiang W; Wang Y; Wu J; Saiyin H; Qiao X; Mei X; Guo B; Fang X; Zhang L; Lou H; Wu C; Qiao S
PLoS One; 2012; 7(8):e42976. PubMed ID: 22927944
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
[TBL] [Abstract][Full Text] [Related]
8. Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells.
Hurst DR; Xie Y; Vaidya KS; Mehta A; Moore BP; Accavitti-Loper MA; Samant RS; Saxena R; Silveira AC; Welch DR
J Biol Chem; 2008 Mar; 283(12):7438-44. PubMed ID: 18211900
[TBL] [Abstract][Full Text] [Related]
9. Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer.
Allan AL; George R; Vantyghem SA; Lee MW; Hodgson NC; Engel CJ; Holliday RL; Girvan DP; Scott LA; Postenka CO; Al-Katib W; Stitt LW; Uede T; Chambers AF; Tuck AB
Am J Pathol; 2006 Jul; 169(1):233-46. PubMed ID: 16816376
[TBL] [Abstract][Full Text] [Related]
10. Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells.
Zhang Y; Ye L; Tan Y; Sun P; Ji K; Jiang WG
Anticancer Res; 2014 Mar; 34(3):1417-26. PubMed ID: 24596389
[TBL] [Abstract][Full Text] [Related]
11. Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells.
Cicek M; Samant RS; Kinter M; Welch DR; Casey G
Clin Exp Metastasis; 2004; 21(2):149-57. PubMed ID: 15168732
[TBL] [Abstract][Full Text] [Related]
12. Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor.
Yang L; Zhao W; Zuo WS; Wei L; Song XR; Wang XW; Zheng G; Zheng MZ
Chin Med J (Engl); 2012 Jan; 125(2):293-9. PubMed ID: 22340562
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts.
Suzuki M; Mose E; Galloy C; Tarin D
Am J Pathol; 2007 Aug; 171(2):682-92. PubMed ID: 17620367
[TBL] [Abstract][Full Text] [Related]
15. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
16. Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer.
Cheng HC; Liu YP; Shan YS; Huang CY; Lin FC; Lin LC; Lee L; Tsai CH; Hsiao M; Lu PJ
Carcinogenesis; 2013 Nov; 34(11):2452-9. PubMed ID: 23774402
[TBL] [Abstract][Full Text] [Related]
17. High level of messenger RNA for BRMS1 in primary breast carcinomas is associated with poor prognosis.
Lombardi G; Di Cristofano C; Capodanno A; Iorio MC; Aretini P; Isola P; Tancredi M; Collecchi P; Naccarato AG; Porta RP; Bevilacqua G; Caligo MA
Int J Cancer; 2007 Mar; 120(6):1169-78. PubMed ID: 17163420
[TBL] [Abstract][Full Text] [Related]
18. Analysis of mechanisms underlying BRMS1 suppression of metastasis.
Samant RS; Seraj MJ; Saunders MM; Sakamaki TS; Shevde LA; Harms JF; Leonard TO; Goldberg SF; Budgeon L; Meehan WJ; Winter CR; Christensen ND; Verderame MF; Donahue HJ; Welch DR
Clin Exp Metastasis; 2000; 18(8):683-93. PubMed ID: 11827072
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
